Protherics PLC announces Total Voting Rights
July 02 2008 - 5:30AM
Marketwired
CHESHIRE, UK , the international biopharmaceutical company
focused on critical care and cancer, notifies the market of the
following: Protherics' issued share capital consists of 340,417,123
ordinary shares with a nominal value of 2 pence each, with voting
rights. Protherics does not hold any ordinary shares in Treasury.
Therefore, the total number of voting rights in Protherics is
340,417,123. The above figure may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, Protherics under the Financial Services Authority's
Disclosure and Transparency Rules. / Ends / For further information
please contact: Protherics Nick Staples, Director of Corporate
Affairs +44 (0) 7919 480510 Julie Vickers, Company Secretary +44
(0)1928 518010 Financial Dynamics - press enquiries London: Ben
Atwell, Lara Mott +44 (0) 20 7831 3113 New York: John Capodanno,
Jonathan Birt +1 212 850 5600 Or visit www.protherics.com This
information is provided by RNS The company news service from the
London Stock Exchange END
Contacts: RNS Customer Services 0044-207797-4400 Email Contact
http://www.rns.com
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jul 2023 to Jul 2024
